<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; menace</title>
	<atom:link href="http://www.tapanray.in/tag/menace/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Is India in The Eye of The AMR Storm?</title>
		<link>http://www.tapanray.in/is-india-in-the-eye-of-the-amr-storm/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-india-in-the-eye-of-the-amr-storm</link>
		<comments>http://www.tapanray.in/is-india-in-the-eye-of-the-amr-storm/#comments</comments>
		<pubDate>Mon, 26 Aug 2019 00:00:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[AMR]]></category>
		<category><![CDATA[AMR capital]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[Antimicrobial]]></category>
		<category><![CDATA[Ayushman Bharat]]></category>
		<category><![CDATA[care]]></category>
		<category><![CDATA[Eye of the storm]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[Issues]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[resistance]]></category>
		<category><![CDATA[sociocultural]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[UHC]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9684</guid>
		<description><![CDATA[‘With 700,000 people losing battle to antimicrobial resistance (AMR) per year and another 10 million projected to die from it by 2050, AMR alone is killing more people than cancer and road traffic accidents combined together.’ This was highlighted in &#8230; <a href="http://www.tapanray.in/is-india-in-the-eye-of-the-amr-storm/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/is-india-in-the-eye-of-the-amr-storm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Blockchain: A Game Changer For Safe Medicines</title>
		<link>http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=blockchain-a-game-changer-for-safe-medicines</link>
		<comments>http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/#comments</comments>
		<pubDate>Mon, 09 Jul 2018 00:00:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[anti-counterfeit]]></category>
		<category><![CDATA[Blockchain]]></category>
		<category><![CDATA[Changer]]></category>
		<category><![CDATA[combating]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[DTAB]]></category>
		<category><![CDATA[economic]]></category>
		<category><![CDATA[Fake]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Genentech]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[measures]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[Niti]]></category>
		<category><![CDATA[Niti Aayog]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[safe]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Spurious]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9049</guid>
		<description><![CDATA[‘Your medicine box may have fake drugs’ was the March 18, 2018 headline of a popular pan Indian news daily. Just the year before, the 2017 report of the World Health Organization (WHO), also flagged that around 10.5 percent of all medicines in &#8230; <a href="http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/blockchain-a-game-changer-for-safe-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Counterfeit Drugs and ACTA: Should the global menace related to &#8216;Public Health and Safety&#8217; be mixed-up with Intellectual Property Rights?</title>
		<link>http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights</link>
		<comments>http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/#comments</comments>
		<pubDate>Mon, 02 Jul 2012 00:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ACTA]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[be]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Intellectual]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[mixed-up]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Property]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[related]]></category>
		<category><![CDATA[Rights]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=72</guid>
		<description><![CDATA[Here in this article, I am talking about drugs or medicines, which you may ultimately land up into buying, quite innocently though, against your doctor’s prescriptions, without having an inkling that these drugs can push you into serious health hazards, &#8230; <a href="http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/counterfeit-drugs-and-acta-should-the-global-menace-related-to-public-health-and-safety-be-mixed-up-with-intellectual-property-rights/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The issue of ‘Counterfeit Drugs’ in India: An “Ostrich Syndrome’</title>
		<link>http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome</link>
		<comments>http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/#comments</comments>
		<pubDate>Mon, 14 Feb 2011 00:30:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ACTA]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Dubai]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[hazard]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Ostrich]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[potential]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[related]]></category>
		<category><![CDATA[Syndrome]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[trademark]]></category>
		<category><![CDATA[USFDA]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=302</guid>
		<description><![CDATA[Ellen‘t Hoen, former Policy Advocacy Director of MSF’s Campaign for Access to Essential Medicines wrote in April 2009 as follows: “People often seem to confuse counterfeit, substandard and generic medicines – using the terms interchangeably. But they are very separate &#8230; <a href="http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-issue-of-counterfeit-drugs-in-india-an-ostrich-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To prevent ‘counterfeit medicines’ from reaching the patients is the nation&#8217;s public health responsibility: Are we still in a denial mode to even accept the existence of this public health menace?</title>
		<link>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h</link>
		<comments>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 01:00:00 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[accept]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[denial]]></category>
		<category><![CDATA[Even]]></category>
		<category><![CDATA[existence]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[Ministry]]></category>
		<category><![CDATA[mode]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[prevent]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reaching]]></category>
		<category><![CDATA[responsibility]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[this]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=721</guid>
		<description><![CDATA[In November 7, 2009, Financial Express reported with a headline,”Generic drug companies see a bitter pill in counterfeit&#8220;, because some believe that it has an in-built intellectual property right connotation. The dictionary definition: The word ‘counterfeit’ may be defined as &#8230; <a href="http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-prevent-counterfeit-medicines-from-reaching-the-patients-is-the-nations-public-health-responsibility-are-we-still-in-a-denial-mode-to-even-accept-the-existence-of-this-public-h/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Concerted action by all stakeholders on counterfeit medicines is the need of the hour.</title>
		<link>http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour</link>
		<comments>http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 00:30:06 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[ACTA]]></category>
		<category><![CDATA[action]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Concerted]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[hour]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[stakeholders]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=768</guid>
		<description><![CDATA[The concern of some section of the stakeholders that IPR is being extended to the definition of counterfeit medicines, in my view, is misplaced. As even in India, &#8216;misbranding&#8217; though an integral part of IPR, is considered as a public &#8230; <a href="http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/concerted-action-by-all-stakeholders-on-counterfeit-medicines-is-the-need-of-the-hour/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tackling the menace of counterfeit medicines – vested interests or petty sentiments should not make the pressing public healthcare issue irrelevant.</title>
		<link>http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant</link>
		<comments>http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/#comments</comments>
		<pubDate>Mon, 29 Jun 2009 00:30:20 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[interests]]></category>
		<category><![CDATA[irrelevant. pharmaceuticals]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[Make]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[petty]]></category>
		<category><![CDATA[pressing]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sentiments]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Tackling]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[vested]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=848</guid>
		<description><![CDATA[There are following three clearly emerging views on the global issue of counterfeit drugs:1. The innovator companies feel that the generic pharmaceutical industry and the drug regulators are not really very keen to effectively address and resolve this global public &#8230; <a href="http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Growing menace of counterfeit drugs in India: why is the domestic pharmaceutical industry still so apprehensive with the new Amendments of the ACT?</title>
		<link>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2</link>
		<comments>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/#comments</comments>
		<pubDate>Wed, 29 Apr 2009 00:30:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Amendments]]></category>
		<category><![CDATA[apprehensive]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[so]]></category>
		<category><![CDATA[still]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[why]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=903</guid>
		<description><![CDATA[The growing menace of Counterfeit drugs has remained a serious threat to the healthcare space of India. Do we have any credible data to assess the magnitude of this menace in India? No we do not have, as yet. At &#8230; <a href="http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/growing-menace-of-counterfeit-drugs-in-india-why-is-the-domestic-pharmaceutical-industry-still-so-apprehensive-with-the-new-amendments-of-the-act-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
